Press Releases 2021PDF DOWNLOAD VIEW ALL NEWS
Enters into Private Placement for Proceeds of $100,000
Toronto, ON – July 23, 2021 – Leveljump Healthcare Corp. (TSXV: JUMP) (“Leveljump” or “the “Company”) wishes to announce that it has entered into a private placement agreement with a corporate subscriber to issue 250,000 common shares at a price of $0.40 per share for gross proceeds of $100,000. There are no finder’s fees payable in connection with this placement. The proceeds will be allocated by the Company primarily towards the creation of additional online content in various social media platforms. Such content shall be proprietary to Leveljump.
Closing of this placement is subject to the consent of the TSX Venture Exchange.
All securities issued will be subject to a hold period of four months and one day pursuant to applicable securities laws.
Additionally the Company issued 2,000 shares as settlement for $800 of debt to two employees on June 9, 2021.
About LevelJump Healthcare
Leveljump Healthcare Corp., (TSXV: JUMP) is building a national medical diagnostic imaging company and brand, primarily by providing teleradiology (remote radiology) services to its client hospitals and imaging centers. Additionally, JUMP plans to expand through the acquisition of independent healthcare facilities focused on diagnostic imaging as well as acquiring new disruptive imaging technologies.
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
Mitchell Geisler, Chief Executive Officer
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.